Revenue

12 Months Ended

Dec. 31, 2024

Revenue Recognition [Abstract]

Revenue

Revenue

The Company recorded the following revenues for the years ended December 31, 2024, 2023, and 2022 (in thousands):

	Years Ended December 31,
	2024		2023		2022
ORLADEYO:
U.S.	$	385,961	$	288,361	$	226,358
Outside of U.S.	51,699		37,629		25,275
Total ORLADEYO	437,660		325,990		251,633
Other revenues	13,052		5,422		19,194
Total revenues	$	450,712	$	331,412	$	270,827

ORLADEYO revenues represent total revenues from product sales, collaborative revenues, and royalties. Other revenues primarily relate to the Company’s product sales and royalties for peramivir.